Results 191 to 200 of about 107,636 (348)

Psychotropic drug use in patients with autoimmune Addison's disease: a Swedish population-based cohort study [PDF]

Sara Öster, Tim Spelman, Sophie Bensing, Jakob Skov   +3 more
openalex   +1 more source

Treatment of Depression: Are Psychotropic Drugs Overdosed in Women and in the Elderly? Dosages of Psychotropic Drugs by Sex and Age in Clinical Routine [PDF]

, 2020
W. Greil, Mateo de Bardeci, Xueqiong Bernegger, Katja Cattapan, Hans H. Stassen, Marcel Sieberer, R. Grohmann, Sermin Toto   +7 more
openalex   +1 more source

Commentary on Borodovsky et al.: Enhancing research on THC quantification—Consumer awareness through accurate labelling

Addiction, Volume 120, Issue 4, Page 686-687, April 2025.
Rachel Lees Thorne, Tom P. Freeman
wiley   +1 more source

Varenicline for cannabis use disorder: A randomized controlled trial

Addiction, EarlyView.
Abstract Background and aims Although cannabis use is widespread and prevalence of cannabis use disorder (CUD) is increasing, limited advancements have been made in CUD medication development. The objective of this study was to test the efficacy of varenicline with medical management for reducing cannabis use in treatment‐seeking individuals with CUD ...
Aimee L. McRae‐Clark, Kevin M. Gray, Nathaniel L. Baker, Brian J. Sherman, Bryan Tolliver, Jessica Burt, Alonzo Steplight, Elizabeth Chapman, Amanda Wagner   +8 more
wiley   +1 more source

Perceptual Discrepancies of Opioid Analgesics and Psychotropic Drugs: A Cross-Sectional Study of Korean Patients and Physicians. [PDF]

J Clin Med
Lee Y, Chun EH, Minn YK, Ahn SH, Kim JH, Kang HY, Lee HS, Kim JE.   +7 more
europepmc   +1 more source

Addiction‐related problems in Japan: A regional perspective

Addiction, EarlyView.
Abstract Japan's addiction landscape appears paradoxical. The lifetime use of illicit drugs is among the lowest in Organisation for Economic Cooperation and Development countries, but harm from alcohol, tobacco, and gambling ranks among the world's highest.
Soichiro Ide, Yoko Nishitani, Masahiko Sumitani, Masabumi Minami, Tadashi Isa, Masako Iseki, Michiko Ohkura, Hitoshi Okamoto, Tetsuro Kikuchi, Yuko Sekino, Hidehiko Takahashi, Kenji Takeuchi, Atsumi Nitta, Takeshi Honjo, Hiroshi Matsumoto, Tsuyoshi Miyakawa, Toshiya Murai, Toshihiko Matsumoto, Kazuyuki Nakagome, Kazutaka Ikeda   +19 more
wiley   +1 more source

Comparing the effect of sympathomimetic/anticholinergic psychotropic drugs with that of non-sympathomimetic/anticholinergic psychotropic drugs on IOP and angle parameters among patients on long-term therapy. [PDF]

Indian J Ophthalmol
Behera G, Lenin J, Bharadwaj B, Mahalingam K, Ram A, Natarajan K, Bascarane S, Kaliaperumal S, Dolli K.   +8 more
europepmc   +1 more source

Meeting the challenge of injection drug use and HIV in Armenia [PDF]

, 2005
Markosyan, Karine
core  

Rare but relevant: Ibogaine and cardiovascular complications—prolonged QT interval and ventricular arrhythmias

Addiction, EarlyView.
Abstract Revived interest in psychedelic‐assisted therapies has also renewed focus on ibogaine, a psychoactive alkaloid, for its notable anti‐addictive potential. Evidence from observational, open‐label, and limited randomized placebo‐controlled trials indicates that ibogaine and its metabolite noribogaine reduce craving and withdrawal symptoms in ...
Tibor Markus Brunt
wiley   +1 more source

Systematic review of the use of prescription and non-prescription psychotropic drugs and their relation with mental health in university population. [PDF]

Front Psychol
Espitia-Cepeda C, González-Amado B, Simó-Algado S, Villanueva-Blasco VJ.   +3 more
europepmc   +1 more source